{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:07:15Z","timestamp":1789704435501,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["PG11203-0189"],"award-info":[{"award-number":["PG11203-0189"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-006-109-MY2"],"award-info":[{"award-number":["112-2314-B-006-109-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2314-B-006-108"],"award-info":[{"award-number":["114-2314-B-006-108"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jmii.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T17:12:12Z","timestamp":1769533932000},"page":"565-572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative analysis of clinical outcomes and short-term treatment response of sputum microbiome between eosinophilic and non-eosinophilic COPD acute exacerbation"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1026-1605","authenticated-orcid":false,"given":"Tsunglin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6865-1502","authenticated-orcid":false,"given":"Ching-Han","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4015-1052","authenticated-orcid":false,"given":"Po-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiu-Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Hsi","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hsiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuen-Lin","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ching","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3283-9145","authenticated-orcid":false,"given":"Chiao-Hsiung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-7288","authenticated-orcid":false,"given":"Chin-Wei","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jmii.2026.01.004_bib1","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1016\/S2214-109X(23)00217-6","article-title":"The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study","volume":"11","author":"Chen","year":"2023","journal-title":"Lancet Global Health"},{"issue":"10","key":"10.1016\/j.jmii.2026.01.004_bib2","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.202209-1748SO","article-title":"Phenotypes, etiotypes, and endotypes of exacerbations of chronic obstructive pulmonary disease","volume":"208","author":"Bhatt","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2026.01.004_bib3","article-title":"Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial","author":"Ramakrishnan","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.jmii.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(19)30176-6","article-title":"Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial","volume":"7","author":"Sivapalan","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.jmii.2026.01.004_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1803185","article-title":"C-Reactive protein testing to guide antibiotic prescribing for COPD exacerbations","volume":"381","author":"Butler","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jmii.2026.01.004_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jmii.2026.01.004_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.chest.2016.01.026","article-title":"Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD","volume":"150","author":"Bafadhel","year":"2016","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jmii.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/resp.13660","article-title":"Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations","volume":"25","author":"Ko","year":"2020","journal-title":"Respirology"},{"issue":"9","key":"10.1016\/j.jmii.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The copenhagen general population study","volume":"193","author":"Vedel-Krogh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jmii.2026.01.004_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/20018525.2020.1757274","article-title":"Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis","volume":"7","author":"Jabarkhil","year":"2020","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.jmii.2026.01.004_bib11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2147\/COPD.S197361","article-title":"The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease","volume":"14","author":"Choi","year":"2019","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"1","key":"10.1016\/j.jmii.2026.01.004_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12931-017-0570-5","article-title":"Blood and sputum eosinophils in COPD; relationship with bacterial load","volume":"18","author":"Kolsum","year":"2017","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.jmii.2026.01.004_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12931-019-1246-0","article-title":"Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety","volume":"20","author":"Li","year":"2019","journal-title":"Respir Res"},{"issue":"10","key":"10.1016\/j.jmii.2026.01.004_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1164\/rccm.202210-1865OC","article-title":"Lower airway dysbiosis augments lung inflammatory injury in mild-to-moderate chronic obstructive pulmonary disease","volume":"208","author":"Sulaiman","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jmii.2026.01.004_bib15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1164\/rccm.201806-1135OC","article-title":"Sputum microbiome is associated with 1-Year mortality after chronic obstructive pulmonary disease hospitalizations","volume":"199","author":"Leitao Filho","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.jmii.2026.01.004_bib16","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/rccm.202009-3448OC","article-title":"Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis","volume":"203","author":"Wang","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jmii.2026.01.004_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/thoraxjnl-2017-210408","article-title":"Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations","volume":"73","author":"Mayhew","year":"2018","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.jmii.2026.01.004_bib18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1183\/13993003.01406-2015","article-title":"Lung microbiome dynamics in COPD exacerbations","volume":"47","author":"Wang","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmii.2026.01.004_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107586","article-title":"Chronic obstructive pulmonary disease and the airway microbiome: a review for clinicians","volume":"225","author":"Luo","year":"2024","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.jmii.2026.01.004_bib20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G\u2217Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"issue":"5","key":"10.1016\/j.jmii.2026.01.004_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jmii.2026.01.004_bib22","article-title":"Blood eosinophils and clinical outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease: a propensity score matching analysis of real-world data in China","volume":"8","author":"Cui","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.jmii.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jaip.2017.10.004","article-title":"Relationship of blood eosinophil count to exacerbations in chronic obstructive pulmonary disease","volume":"6","author":"Zeiger","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.jmii.2026.01.004_bib24","article-title":"Stability in eosinophil categorisation during subsequent severe exacerbations of COPD","volume":"8","author":"Citgez","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jmii.2026.01.004_bib25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2147\/COPD.S245056","article-title":"Blood eosinophilia and its stability in hospitalized COPD exacerbations are associated with lower risk of all-cause mortality","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"1","key":"10.1016\/j.jmii.2026.01.004_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00427-2018","article-title":"The reproducibility of COPD blood eosinophil counts","volume":"52","author":"Southworth","year":"2018","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.jmii.2026.01.004_bib27","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201701-0009LE","article-title":"Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts","volume":"195","author":"Oshagbemi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jmii.2026.01.004_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-021-01443-4","article-title":"The association between eosinophilic exacerbation and eosinophilic levels in stable COPD","volume":"21","author":"Kang","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"9","key":"10.1016\/j.jmii.2026.01.004_bib29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2213-2600(16)30148-5","article-title":"Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis","volume":"4","author":"Pavord","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.jmii.2026.01.004_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jmii.2026.01.004_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12016-015-8525-4","article-title":"The eosinophil in infection","volume":"50","author":"Ravin","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"10.1016\/j.jmii.2026.01.004_bib32","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1084\/jem.20172049","article-title":"Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation","volume":"215","author":"Arnold","year":"2018","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jmii.2026.01.004_bib33","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00543-2020","article-title":"Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses","volume":"7","author":"Csoma","year":"2021","journal-title":"ERJ Open Res"},{"issue":"6","key":"10.1016\/j.jmii.2026.01.004_bib34","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/all.14661","article-title":"Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease","volume":"76","author":"Higham","year":"2021","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.jmii.2026.01.004_bib35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41579-022-00821-x","article-title":"The dynamic lung microbiome in health and disease","volume":"21","author":"Natalini","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.jmii.2026.01.004_bib36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/jleuko\/qiae153","article-title":"The relevance of eosinophils in chronic obstructive pulmonary disease: inflammation, microbiome, and clinical outcomes","volume":"116","author":"Higham","year":"2024","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jmii.2026.01.004_bib37","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.15.04152","article-title":"Prognostic risk profiling in COPD using global initiative for chronic obstructive lung disease 2023 ABE and comorbidity assessment: evidence from a register-based COPD cohort","volume":"15","author":"Lin","year":"2025","journal-title":"J Glob Health"},{"issue":"1","key":"10.1016\/j.jmii.2026.01.004_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s40001-023-01136-0","article-title":"The impact of the duration of the integrated disease management program on COPD-Related outcomes","volume":"28","author":"Lin","year":"2023","journal-title":"Eur J Med Res"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:41:33Z","timestamp":1789702893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118226000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1684118226000174"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2026.01.004","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of clinical outcomes and short-term treatment response of sputum microbiome between eosinophilic and non-eosinophilic COPD acute exacerbation","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}